Physiology

Edited by: Neeraja Sankaran A.S. Weyrich, X.L. Ma, D.J. Lefer, K.H. Albertine, A.M. Lefer, "In vivo neutralization of P-selectinprotects feline heart andendothelium in myocardialischemia and reperfusion injury," Journal of Clinical Investigation, 91:2620-29, 1993. (Cited in 53publications through February 1995) Comments by Allan M. Lefer,Thomas Jefferson University GAINS ON THE HEART FRONT: Allan Lefer's team has shown that neutralizing the glycoprotein P-selectin can confer protection agains

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Edited by: Neeraja Sankaran
A.S. Weyrich, X.L. Ma, D.J. Lefer, K.H. Albertine, A.M. Lefer, "In vivo neutralization of P-selectinprotects feline heart andendothelium in myocardialischemia and reperfusion injury," Journal of Clinical Investigation, 91:2620-29, 1993. (Cited in 53publications through February 1995)

Comments by Allan M. Lefer,Thomas Jefferson University


GAINS ON THE HEART FRONT: Allan Lefer's team has shown that neutralizing the glycoprotein P-selectin can confer protection against injury to the heart cells and hence, heart attacks in cats.
Using an animal model for heart attack, Allan Lefer's team of researchers at Thomas Jefferson University have reported success in protecting the heart muscle cells from damage by neutralizing a group of glycoproteins called selectins.

Normally present in platelets, leukocytes, and endothelial cells, the selectins play a role in cellular communication and movement. Lefer, chairman of the physiology department at Jefferson and a professor in the department, explains that these glycoproteins exert a harmful ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies